Margaret Prendergast,
Director of Bioengineering and Pharmaceutical Development,
Allevi, Inc.
Margaret Prendergast is the Director of Bioengineering and Pharmaceutical Development at Allevi. As director, Margaret leads bioink development for the fabrication of custom 3D living tissue and facilitates pharmaceutical collaborations.
Automating 3D Biology
Thursday, 7 June 2018 at 13:30
Add to Calendar ▼2018-06-07 13:30:002018-06-07 14:30:00Europe/LondonAutomating 3D BiologyBioprinting and 3D-Printing in the Life Sciences EU 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Biology exists in 3D, but it is most often studied in oversimplified 2D models. Extrusion biofabrication finally presents scientists with the capability to create complex 3D biological environments. Standardized, automated biofabrication allows for high-throughput versatility, demonstrating great potential for a variety of applications, including high-throughput screening, organ-on-a-chip fabrication, and personalized medicine. In this presentation, learn more about the limitless possibilities of extrusion biofabrication.
Add to Calendar ▼2018-06-07 00:00:002018-06-08 00:00:00Europe/LondonBioprinting and 3D-Printing in the Life Sciences EU 2018Bioprinting and 3D-Printing in the Life Sciences EU 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2018-06-07 13:30:002018-06-07 14:30:00Europe/LondonAutomating 3D BiologyBioprinting and 3D-Printing in the Life Sciences EU 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
